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O R I G I N A L  R E S E A R C H
Prospective Evaluation of Association Between 
Negative Emotions and Heart Failure Symptom 
Severity
This article was published in the following Dove Press journal: 
Psychology Research and Behavior Management
Kyoung Suk Lee1 
Terry A Lennie 2 
Debra K Moser2
1Seoul National University, College of 
Nursing, The Research Institute of 
Nursing Science, Seoul, South Korea; 
2University of Kentucky, College of 
Nursing, Lexington, KY, USA 
Background: Prior studies of symptoms in heart failure (HF) were largely cross-sectional 
and symptoms were measured using retrospective recall. Because negative emotions influ-
ence information processing, retrospective symptom reports by patients with depressive 
symptoms and anxiety may be biased. The purpose of this study was to determine whether 
there are differences in patterns of symptom changes, measured prospectively, over 15 days 
by levels of depressive symptoms and anxiety.
Methods: HF patients (N=52) rated daily symptom severity for shortness of breath 
(SOB), fatigue, sleep disturbance, and edema over 15 days on a 10-point visual analogue 
scale. Patients were grouped into higher vs lower levels of depressive symptoms and 
anxiety, respectively, based on median scores of Brief Symptom Inventory subscales. 
Latent growth curve modeling was used to examine whether patterns of symptom 
changes over 15 days differed in higher vs lower levels of depressive symptom and 
anxiety groups.
Results: Those in the higher depressive symptom group had lower levels of baseline 
symptom severity in SOB (β: −1.46), fatigue (β: −1.71), sleep disturbance (β: −1.78), and 
edema (β: −1.97) than those in the lower depressive symptom group. However, there were no 
significant differences in rates of changes in the severity of any of the four symptoms 
between groups. Anxiety was not associated with baseline severity of symptoms or rates 
of changes in any of the four symptoms.
Conclusion: Depressive symptoms, but not anxiety, were associated with daily symptom 
experience. HF patients with higher levels of depressive symptoms may perceive their 
symptom severity differently than patients with lower levels of depressive symptoms.
Keywords: depressive symptoms, anxiety, heart failure, symptoms
Introduction
Heart failure (HF) is a serious health concern in the United States with high volume 
and staggering Medicare program expenditure. In the United States, approximately 
5.7 million adults have HF, and an additional 3 million will have HF by 2030.1 HF 
is the most common reason for hospital admissions among Medicare beneficiaries, 
with 40% and 65% of rehospitalization rates at 3 months and 1 year.2
Accurate symptom perception is essential for patients with HF to effectively 
manage their HF, seek care in a timely manner, and prevent repeated hospitalizations.3 
However, some patients wait up to 7 days or more before seeking medical help.4,5 
About 40% of HF patients who had been diagnosed with HF for more than 2 months 
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admitted that they were unable to recognize typical symp-
toms of HF, such as dyspnea, fatigue and orthopnea, as 
evidence of worsening HF.6
The Common-Sense Model of Illness Representations 
describes how individuals respond to health threats by 
forming two distinct dimensions of illness 
representations.7 Cognitive illness representations can be 
shaped based on the information available to the indivi-
duals (eg, previous experiences and knowledge). 
Emotional illness representations capture feelings related 
to illness. The model suggests that cognitive and emo-
tional illness representations are interrelated and simulta-
neously influence individuals’ responses to health threats. 
Previous studies have showed that the two dimensions of 
illness representations are associated with health-related 
behaviors and outcomes in a variety of groups of patients 
including patients with HF.8–10
Negative emotions, such as depression and anxiety, are 
barriers to accurate symptom perception because negative 
emotions affect cognitive processing, such as attention and 
memory.11–13 Patients with higher levels of depressive 
symptoms and lower levels of anxiety are more likely to 
have longer delay time from the onset of worsening HF to 
care-seeking.4,14 Depressive symptoms independently pre-
dicted the number of physical symptoms that HF patients 
experienced over 7 days after adjusting for clinical and 
demographic factors (ie, N-terminal pro-brain natriuretic 
peptide, age, and race).15 These findings suggest that 
negative emotions influence symptom perception in the 
HF population.
Howren and Suls found that depressive and anxious 
moods have a differential effect on retrospective and con-
current symptom reporting.12 In their study, depressed 
mood was related to inflation of retrospective symptom 
reporting, while anxious mood was related to the inflation 
of concurrent symptom reporting.12 However, prior studies 
of symptoms in HF in relation to depressive symptoms and 
anxiety have been mostly cross-sectional and relied on 
retrospective recall of symptoms (eg, symptom experi-
ences during the past week).15,16 This limits our under-
standing of how the day-to-day symptom experience in HF 
patients is influenced by depressive symptoms and anxiety.
To address this gap in knowledge, it is important to 
prospectively investigate the association between HF 
symptom assessment and depressive symptoms and anxi-
ety. The purpose of this study was to determine whether 
there are differences in patterns of symptom severity in 
four major HF symptoms (ie, shortness of breath [SOB], 
fatigue, sleep disturbances, and edema) over 15 days 
between patients with higher and lower levels of depres-
sive symptoms and anxiety, respectively.
Methods
This study was a prospective, longitudinal study in which we 
compared patients’ symptom ratings for 15 consecutive days 
by levels of depressive symptoms and anxiety. Patients were 
recruited from cardiology clinics affiliated with three aca-
demic institutions in the United States and Australia. The 
Institutional Review Boards of all participating institutions 
(University of Kentucky and Australian Catholic University) 
approved this study. This study conforms to the principles of 
the Declaration of Helsinki. Written, signed informed con-
sent was sought and obtained from all participants.
Participants
Patients ≥ 21 years of age with a physician-confirmed diag-
nosis of HF were eligible for this study. Patients were 
excluded for an acute myocardial infarction in the 3 months 
prior to the study enrollment, changes in medication regimens 
in the 3 months prior to the study, a stroke with neurological 
impairment, life-threatening comorbidities (eg, cancer with 
active treatment and end-stage renal disease), obvious cogni-
tive impairments, or inability to read or understand English.
Procedures
Cardiologists and nurses in the clinics consecutively referred 
patients who met the inclusion/exclusion criteria. Patients 
were invited to participate in the study and gave signed, 
written informed consent. After obtaining informed consent, 
baseline appointments were scheduled. At baseline, patients 
were asked to complete questionnaires to assess socio-demo-
graphic and clinical factors, depressive symptoms, and anxi-
ety. Medical records were reviewed to obtain clinical 
characteristics, such as left ventricular ejection fraction 
(LVEF). After patients completed the questionnaires, trained 
research nurses provided patients with a symptom diary to rate 
their symptoms for 15 days after returning to home and taught 
them in detail how to complete the diary (eg, rate symptoms at 
the same time every day). When patients returned their com-
pleted symptom diaries, research nurses reviewed the diary 
with patients to resolve ambiguities in ratings.
Measures
Symptom Diary
Daily symptoms were assessed with the Daily Symptom 
Scale,17 which is a self-report, paper-pencil type of the 
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symptom diary. Patients are asked to rate the severity of 
four symptoms (ie, SOB, fatigue, sleep disturbance, and 
edema) daily for 15 days. Symptom severity was rated 
using a 10-point visual analog scale with 0 indicating the 
absence of symptom and 10 indicating the worst the 
symptom could be.
Depressive Symptoms and Anxiety
Depressive symptoms and anxiety were measured using 
the Brief Symptom Inventory (BSI) subscales for depres-
sive symptoms and anxiety, respectively.18 The advantage 
of using the BSI over other measures (eg, Beck Depression 
Inventory) is that there are no somatic symptom items, 
such as sleep disturbances, which may be confounded with 
HF symptoms and the instrument is short and easy to 
understand.
There are six items per each subscale of BSI. 
Patients are asked to rate how much they have been 
bothered by symptoms of depression or anxiety in the 
past 7 days on a 5-point scale (0= “not at all” to 
4=“extremely”). Total scores are obtained by averaging 
item scores and can range from 0 to 4, with higher 
scores indicating higher levels of depressive symptoms 
and anxiety. The validity and reliability of the BSI have 
been demonstrated.18
Sociodemographic and Clinical Data
Data on following variables were collected via patient 
interview and medical records review: age, gender, ethni-
city, living arrangement, LVEF, New York Heart 
Association (NYHA) functional classification, comorbid-
ities, and medication regimens. Patients were categorized 
as having either non-preserved systolic function (LVEF ≤ 
40%) or preserved systolic function (LVEF > 40%). 
Trained research nurse carefully conducted in-depth struc-
tured patient interviews to determine NYHA classification.
Statistical Analyses
Medians of baseline scores of the BSI subscale of depres-
sive symptoms (median score= 0.5) and anxiety (median 
score =0.5) were used to define higher vs lower levels of 
depressive symptoms and anxiety because there are only 
established cut-points for healthy adults. Independent t- 
tests, Mann–Whitney test, chi-square tests, or Fisher’s 
exact tests were used as appropriate to compare character-
istics of patients between lower and higher levels of 
depressive symptoms and anxiety.
Latent growth curve modeling was done with Mplus 
7.1. We built separate latent growth curve models by 
median scores of depressive symptoms (ie, lower vs higher 
levels of depressive symptoms groups) and anxiety (ie, 
lower vs higher levels of anxiety groups).
We first built simple latent growth curves for four 
symptoms (ie, SOB, fatigue, sleep disturbances, and 
edema) for each depressive symptom groups (ie, higher 
vs lower), to compare the average trajectory of symptom 
severity for 15 consecutive days by levels of depressive 
symptoms. We then incorporated covariates (ie, age, gen-
der, and NYHA class) in the model to determine whether 
depressive symptom groups are associated with the initial 
level (ie, intercept) and rate of change (ie, slope) in symp-
tom severity after adjusting for covariates. We followed 
the same steps described above (latent growth curves 
modeling without and with covariates) to compare the 
average trajectory of symptom severity between patients 
with higher and lower levels of anxiety.
The trajectory of symptom severity is characterized by 
latent growth factors: an intercept (ie, estimate of baseline 
level) and linear slope (ie, rate of change over time). 
Model fit was examined with a standardized root-mean- 
square residual (SRMR<0.10), a root-mean-square error of 
approximation (RMSEA <0.08), a comparative fit index 
(CFI>0.90), and Tucker–Lewis Index (TLI >0.90).
Of 3120 symptom diary entries for 52 patients, 23 
missing entries were found. Of 23 missing entries, there 
were no missing entries for two or more consecutive days. 
We imputed the missing values by averaging before and 
after the missing values to yield a more complete data set 
without a loss of power.
Results
Sample Characteristics
As shown in Table 1, the mean age of the patients (n=52) 
was 61 years with a range of 23–87 years. The sample was 
predominantly Caucasian, male, currently living with 
someone, and overweight or obese. The majority of the 
patients had non-preserved systolic function (LVEF ≤ 
40%). All patients were symptomatic (NYHA class II– 
IV) and more than half of the patients were classified in 
NYHA III/IV. The most common comorbid conditions 
were hypertension followed by diabetes.
When comparing sample characteristics between patients 
with lower and higher levels of depressive symptoms (Table 
1), there were no significant differences except for gender 
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and anxiety. Patients with higher levels of depressive symp-
toms were more likely to be women and have higher levels of 
anxiety than patients with lower levels of depressive symp-
toms. Compared with patients with lower levels of anxiety, 
patients with higher levels of anxiety were more likely to be 
younger, have preserved systolic function (LVEF>40%), and 
higher levels of depressive symptoms (Table 1).
Latent Growth Curve Modeling
Depressive Symptom Groups
Simple Latent Growth Curve Models 
Overall, patients experienced no meaningful rates of changes 
in SOB, fatigue, sleep disturbance, and edema over 15 days 
(slopes for the four symptoms p-values > 0.05) between 
patients with lower and higher levels of depressive 
Table 1 Sample Characteristics (N=52)
Total Lower Levels of 
Depressive Symptoms 
(n=26)
Higher Levels of 
Depressive Symptoms 
(n=26)
Lower Levels of 
Anxiety (n=27)
Higher Levels of 
Anxiety (n=25)
Age, yearsb 61 ± 14 63 ± 15 60 ± 13 65 ± 15 57 ± 11
Gendera
Male 30 (57.7) 19 (73.1) 11 (42.3) 18 (66.7) 12 (48.0)
Female 22 (42.3) 7 (26.9) 15 (57.7) 9 (33.3) 13 (52.0)
Living with someone 45 (86.5) 23 (88.5) 22 (84.6) 24 (88.9) 21 (84.0)
Ethnicity
Caucasian 34 (65.4) 17 (65.4) 17 (65.4) 17 (63.0) 17 (68.0)
Others 18 (34.6) 9 (34.6) 9 (34.6) 10 (37.0) 8 (32.0)
Education (n=51) 11 ± 3 11 ± 3 12 ± 3 11 ± 3 12 ± 3
Body mass index (kg/m2) 
(n=49)
<25.0 (normal weight) 14 (28.6) 7 (28.0) 7 (29.2) 6 (24.0) 8 (33.3)
25.0–29.9 (overweight) 15 (30.6) 8 (32.0) 7 (29.2) 10 (40.0) 5 (20.8)
>30.0 (obese) 20 (40.8) 10 (40.0) 10 (41.7) 9 (36.0) 11 (45.8)
NYHA Classb
II 24 (46.2) 15 (57.7) 9 (34.6) 16 (59.3) 8 (32.0)
III/IV 28 (53.8) 11 (42.3) 17 (65.4) 11 (40.7) 17 (68.0)
Left ventricular ejection 
fraction ≤ 40%b (n=49)
40 (81.6) 21 (91.3) 19 (73.1) 23 (95.8) 17 (68.0)
Comorbidities
Hypertension 38 (73.1) 16 (64.0) 22 (84.6) 19 (73.1) 19 (76.0)
CVA or stroke 7 (13.5) 2 (7.7) 5 (19.2) 3 (11.1) 4 (16.0)
Diabetes 19 (36.5) 11 (42.3) 8 (30.8) 9 (33.3) 10 (40.0)
Medications
ACE I or ARB (n=51) 40 (76.9) 20 (76.9) 20 (80.0) 21 (77.8) 19 (79.2)
Beta blockers 40 (76.9) 20 (76.9) 20 (76.9) 20 (74.1) 20 (80.0)
Diuretics 43 (82.7) 21 (80.8) 22 (84.6) 22 (81.5) 21 (84.0)
Digoxin 21 (40.4) 12 (46.2) 9 (34.6) 11 (40.7) 10 (40.0)
Antidepressant 8 (15.4%) 2 (7.7%) 6 (23.1%) 3 (11.1%) 5 (20.0%)
Depressive Symptomsa,b 0.96 ± 0.95 0.19 ± 0.22 1.74 ± 0.73 0.41± 0.64 1.56± 0.87
Anxietya,b 0.73± 0.80 0.24 ± 0.32 1.22± 0.84 0.17 ± 0.19 1.33 ± 0.77
Notes: Value=mean ± SD or N (%); Percentages may not sum to 100% due to rounding or missing values. aIndicates that group differences between higher and lower levels 
of depressive symptoms; bIndicates that group differences between higher and lower levels of anxiety. 
Abbreviations: NYHA, New York Heart Association; HF, heart failure; CVA, cerebrovascular accident; ACE I, angiotensin converting enzyme inhibitors; ARB, angiotensin II 
receptor blockers.
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symptoms (Table 2). However, patients with higher levels of 
depressive symptoms had lower scores of baseline symptom 
severity (intercept) by 1.17 (95% confidence interval [CI] = 
−2.84, −0.75), 1.87 (95% CI=−3.13, −0.61), 2.18 (95% CI= 
−3.66, −0.70), and 1.91 points (95% CI=−3.59, −0.23) for 
SOB, fatigue, sleep disturbance, and edema, respectively, 
than patients with lower levels of depressive symptoms.
Adjusted Latent Growth Curve Models 
There were no significant differences in rates of changes 
(slopes) in the severity of any of the four symptoms between 
the two groups after controlling for age, gender, and NYHA 
class (Figure 1). However, patients with higher levels of 
depressive symptoms had lower levels of baseline symptom 
severity (intercepts) over 15 days in SOB (β: −1.46, 95% CI= 
−2.60, −0.32), fatigue (β: −1.71, 95% CI=−3.08, −0.34), sleep 
disturbance (β: −1.78, 95% CI=−3.35, −0.20), and edema (β: 
−1.97, 95% CI=−3.79, −0.14) compared to patients with 
lower levels of depressive symptoms after adjusting for age, 
gender and NYHA class (Table 2). This indicates that HF 
patients with higher levels of depressive symptoms experi-
enced consistently lower symptom severity over 15 days than 
patients with lower levels of depressive symptoms.
Examining the covariates, women experienced a posi-
tive rate of changes in SOB severity (β: 0.06, 95% 
CI=0.001, 0.12), indicating a small increase in severity 
of SOB over 15 days compared to men. Patients in 
NYHA II reported higher scores of SOB severity at 
Figure 1 Trajectory of symptom severity by depressive symptoms (n=52). 
Notes: ■ = Lower levels of depressive symptoms (raw). ● = Lower levels of depressive symptoms (projected). ◆ = Higher levels of depressive symptoms (raw). ▲ = 
Higher levels of depressive symptoms (projected). The panels (A–D) = shortness of breath, fatigue, sleep disturbance, and edema, respectively. X-axis indicates number of 
days and y-axis indicates levels of symptoms. The baseline symptom severity in all four symptoms (shortness of breath, fatigue, sleep disturbance, and edema) was 
significantly different between patients with higher and lower levels of depressive symptoms. However, there were no significant differences in the rates of changes in any of 
the four symptoms between the two groups.
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baseline (intercept) by 1.53 points than patients in NYHA 
III/IV (95% CI=−2.63, −0.42). Age was associated with a 
negative rate of changes in sleep disturbance (β: −0.004, 
95% CI=−0.01, −0.001), indicating a very small reduction 
in severity of sleep disturbance over 15 days with age.
Anxiety Groups
Simple Latent Growth Curve Models 
There were no significant rates of changes in SOB, fatigue, 
sleep disturbance, and edema over 15 days (slopes for the 
four symptoms p-values > 0.05) between patients with lower 
and higher levels of anxiety (Table 3). There were no sig-
nificant differences in baseline symptom severity (intercept) 
between lower and higher levels of anxiety except for sleep 
disturbance. Patients with higher levels of anxiety had lower 
scores of baseline symptom severity (intercept) by 1.94 
points (95% confidence interval [CI] =−3.48, −0.41), for 
sleep disturbance than patients with lower levels of anxiety.
Adjusted Latent Growth Curve Models 
There were no significant differences in rates of changes 
(slopes) and baseline symptom severity (intercepts) in any 
of the four symptoms between patients with lower and 
higher levels of anxiety symptoms, after controlling for 
age, gender, and NYHA class (Figure 2).
Among covariates, age was associated with a negative 
rate of changes in sleep disturbance severity (β: −0.004, 
95% CI=−0.007, 0.0001), indicating a small decrease in 
severity of sleep disturbance over 15 days as age increases. 
Patients in NYHA II had higher scores of SOB severity at 
baseline (intercept) by 1.61 points than patients in NYHA 
III/IV (95% CI=−2.77, −0.44).
Figure 2 Trajectory of symptom severity by anxiety (n=52). 
Notes: ■ = Lower levels of anxiety (raw). ● = Lower levels of anxiety (projected). ◆ = Higher levels of anxiety (raw). ▲ = Higher levels of anxiety (projected). The panels 
(A–D) = shortness of breath, fatigue, sleep disturbance, and edema, respectively. X-axis indicates number of days and y-axis indicates levels of symptoms. The baseline 
symptom severity in any of the four symptoms (shortness of breath, fatigue, sleep disturbance, and edema) was not significantly different between patients with higher and 
lower levels of anxiety. There were no significant differences in rates of changes in any of the four symptoms between the two groups.
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Discussion
This is the first study on the relationship between negative 
emotions (ie, depressive symptoms and anxiety) and day- 
to-day HF symptom experiences in patients with HF to be 
conducted in a prospective manner. In this study, higher 
levels of depressive symptoms were associated with lower 
levels of symptom severity, a phenomenon that was stable 
over time. However, anxiety was not associated with either 
levels of or changes in symptom severity over time. These 
results suggest that depressive symptoms and anxiety dif-
ferentially influence patients’ daily symptom experiences. 
HF patients with higher levels of depressive symptoms 
appear to perceive their symptom severity differently 
than patients with lower levels of depressive symptoms. 
However, anxiety was not associated with symptom 
experience over 15 days.
Symptoms are subjective sensations indicating a 
departure from normal function. Symptoms are not 
merely reflecting functional or structural abnormalities 
in body systems, but rather the integrated experiences of 
people in the context of their life situations.19,20 Thus, 
symptoms are experienced in a unique way even among 
people with the same symptoms and these experiences 
are influenced by a variety of factors, such as age and 
emotions.3,21,22
Negative emotions, such as depressive symptoms and 
anxiety, influence information processing processes.11–13 
Depressed people tend to deeply focus on self, engage 
less in external environments, be ruminative to stimuli, 
and recall negative experiences more strongly.22–24 These 
characteristics of depressed people may contribute to an 
inaccurate symptom perception, particularly symptom 
reporting from retrospective recalls.
Howren and Suls12 conducted an experimental study in 
which participants were asked two following questions 
after mood induction: how many physical symptoms 
were currently experienced and how many physical symp-
toms had been experienced over 21 days. In their study, 
participants in a depressed mood induction arm reported a 
similar number of symptoms compared to those in a neu-
tral mood induction arm. However, participants in a 
depressed mood induction arm reported a significantly 
larger number of physical symptoms when they were 
asked to recall physical symptoms experienced over 21 
days.12 Similarly, the more depressed patients suffering 
from low back pain are, the greater inaccuracy in the recall 
of pain compared to the actual daily diary pain were 
observed.25 These results indicate that depressive symp-
toms may affect a recall of symptom experiences.
Bekelman and colleagues15 demonstrated the positive 
relationship between depressive symptoms scores and the 
number of physical symptoms experienced over the past 
week in patients with HF. This finding reflects the general 
notion that depressive symptoms may amplify physical 
symptom complaints in HF. However, in our study HF 
patients with higher levels of depressive symptoms con-
sistently experienced lower levels of severity of physical 
symptoms over 15 days. This conflicting finding in our 
study may be related to the fact that we used a symptom 
diary to prospectively assess symptoms instead of asses-
sing symptom experiences by relying on recollection over 
days or weeks. The memory bias in depressive symptoms 
is consistently found in patients with HF in the present 
study.
Unlike depression, in which recall bias is a unique 
characteristic, hypervigilance for threatening information 
is a distinctive feature of anxiety.24 Anxious people have a 
disproportionate tendency to quickly recognize threatening 
stimuli compared to neutral stimuli.24,26 People in a group 
where an anxious mood was induced reported a larger 
number of physical symptoms than people in groups 
where depressed or neutral moods were induced.12 
However, in our study anxiety was not related to daily 
symptom experience. This might be related to the fact that 
attention bias varies depending on levels of anxiety and 
degree of intensity of threats.24,27 Regarding moderately 
threatening cues, highly anxious people showed attentional 
vigilance, while low anxious people showed attentional 
avoidance.27 However, both highly and low anxious peo-
ple exhibited attentional vigilance to highly threatening 
cues.27 In our study, symptom severities for four physical 
symptoms ranged from an average of 6–7 out of 10 points, 
which might not be perceived as highly threatening levels 
of symptoms by patients. Given that levels of symptom 
severity in our sample were stable over 15 days, daily 
similar levels of symptom severity might not be consid-
ered as significant cues to patients’ HF condition, which 
contributes to a lack of attention bias on daily symptom 
experience in our study.
Overall, there were neither positive nor negative rates 
of changes in symptom severity among HF patients 
regardless of levels of depressive symptoms and anxiety 
in our study. This may be related to the fact that we 
recruited patients from out-patient settings who were rela-
tively stable. As significant changes in weights exhibited 
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at least 7 days before hospitalization for HF 
decompensation,28 it is not expected to observe dramatic 
fluctuations of symptom severity in stable patients with HF 
like the sample in our study.
We found that age was associated with a decrease in 
the severity of sleep disturbance. However, the rates of 
changes were so small (β= −0.004 in both depressive 
symptoms and anxiety models) that it is unlikely that 
these rates of changes were clinically significant. The 
initial scores of symptom severity were not associated 
with age in our study. However, there are some studies 
demonstrating age differences in symptom perception. 
Riegel and colleagues (2010) demonstrated that aging 
was associated with poor ability to recognize symptoms 
in patients with HF, which may be explained by changes in 
the process by which sensory nerve receptors receive and 
process stimuli that originate inside the body.29
Unexpectedly, SOB severity scores of patients in 
NYHA III/IV were smaller than scores of patients in 
NYHA II by 1.5 and 1.6 points in depressive symptom 
and anxiety models, respectively. These counter-intuitive 
findings may be related to the fact that NYHA functional 
class was determined by trained research nurses with a 
structural interview, while SOB severity was rated by 
patients in their home environment. NYHA functional 
classes are determined based on the extent to which HF 
symptoms, such as, but not limited to, SOB, limit physical 
activity levels. Although NYHA functional class reflects 
symptom perception to some extent, this is different from 
patients’ perceived SOB severity. A poor agreement 
between clinician- and HF patient-rated NYHA classes 
(kappa statistic=0. 28) was demonstrated,30,31 which may 
indicate the differences between how functional status was 
observed by clinicians and perceived by patients 
themselves.
Implications
Patients with HF make their decisions to seek care based on 
their symptom perception.32 Our findings suggest that differ-
ent symptom perception related to depressive symptoms is a 
reason for worse outcomes in depressed patients in HF. 
Therefore, it is important for clinicians to recognize the 
impact of depressive symptoms on symptom perception in 
HF patients with depressive symptoms to develop strategies 
to improve the accuracy of their symptom perception. One 
possible strategy would be a mindfulness-based intervention, 
which aims at cultivating a non-judgmental, open, and inten-
tional awareness of the present-moment experience (ie, 
mindful awareness).33 From this training, HF patients with 
depressive symptoms can learn to accurately perceive their 
symptoms without reflecting rumination.
Limitations
One limitation of our study is the relatively small sample 
size with the majority of patients who were white and 
men. This limits the generalizability of our findings. Data 
were imputed to minimize a loss of power. However, 
study results were not altered when using the sample 
with a complete set of diary data for 15 days. In this 
study, the daily diary data on symptoms were collected 
using pencil-and-paper diaries. This type of the diary 
does not guarantee that patients did complete the diary 
on time for 15 days although research nurses highlighted 
the importance of completing the diary at the same time 
every day. Model fit of the latent growth curve models 
was not optimal. However, as this study is an exploratory 
purpose, marginal model fit would be satisfactory for this 
study. Because the cutoff scores of the BSI for clinically 
significant depression and anxiety are not established, the 
median split was used to group patients into lower and 
higher levels of depressive symptoms and anxiety in this 
study. In fact, patients classified as higher levels of 
depressive symptoms and anxiety in this study may not 
have clinically significant depression and anxiety because 
the mean scores of the BSI subscales for depressive 
symptoms and anxiety were 0.96 (SD 0.95) and 0.73 
(SD 0.80), respectively. However, the mean scores of 
the BSI for depressive symptoms and anxiety in previous 
studies were below 1.34–36
Conclusion
The findings of our study have significant implications in 
relation to poor outcomes in HF patients with negative 
emotions, particularly, depressive symptoms. We found 
that patient day-to-day symptom experiences were differ-
ent by levels of depressive symptoms, but not anxiety. 
Given that care-seeking decisions are made based on 
symptom perception, inaccurate symptom perception 
related to depressive symptoms may be a reason for 
worse outcomes in depressed patients in HF. However, 
more studies with larger sample sizes are needed to deter-
mine why patients with higher levels of depressive symp-
toms consistently rated their symptom severity lower than 
patients with lower levels of depressive symptoms.
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